Steven Coutre - Medicine Department, Stanford University

基本信息

Career Trajectory

Bio

Clinical Focus
Cancer > Hematology
Cancer > Hematology > Leukemia - Acute and Chronic
Leukemia
Chronic Lymphocytic Leukemia
Multiple Myeloma
All Clinical Focus (11)
Academic Appointments
Professor - Med Center Line, Medicine - Hematology
Member, Stanford Cancer Institute

Research Interests

Papers共 390 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

John C. Byrd,Richard R. Furman,Steven E. Coutre,Ian W. Flinn,Jan A. Burger,Kristie Blum,Jeff P. Sharman,William Wierda,Weiqiang Zhao,Nyla A. Heerema,Ying Luan,Emily A. Liu,James P. Dean,Susan O'Brien

pubmed（2023）

Cited132Views0WOSBibtex

132

Supplementary Appendix from Extended Treatment with Single-Agent Ibrutinib at the 420 Mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Steven E. Coutré,Richard R. Furman,Ian W. Flinn,Jan A. Burger,Kristie Blum,Jeff Sharman,Jeffrey Jones,William Wierda,Weiqiang Zhao,Nyla A. Heerema,Amy J. Johnson,Anh Tran,Cathy Zhou,Elizabeth Bilotti,Danelle F. James,John C. Byrd,Susan O'Brien

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

John C. Byrd,Richard R. Furman,Steven E. Coutre,Ian W. Flinn,Jan A. Burger,Kristie Blum,Jeff P. Sharman,William Wierda,Weiqiang Zhao,Nyla A. Heerema,Ying Luan,Emily A. Liu,James P. Dean,Susan O'Brien

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

John C. Byrd,Richard R. Furman,Steven E. Coutre,Ian W. Flinn,Jan A. Burger,Kristie Blum,Jeff P. Sharman,William Wierda,Weiqiang Zhao,Nyla A. Heerema,Ying Luan,Emily A. Liu,James P. Dean,Susan O'Brien

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

John C. Byrd,Richard R. Furman,Steven E. Coutre,Ian W. Flinn,Jan A. Burger,Kristie Blum,Jeff P. Sharman,William Wierda,Weiqiang Zhao,Nyla A. Heerema,Ying Luan,Emily A. Liu,James P. Dean,Susan O'Brien

openalex（2023）

Cited0Views0Bibtex

Specificity of Immunoglobulin High-Throughput Sequencing Minimal Residual Disease Monitoring in Non-Hodgkin Lymphomas

Navika D. Shukla,Joseph Schroers-Martin,Brian J. Sworder,Karan Raj Kathuria,Stefan Alig,Matthew J. Frank,David B. Miklos,Steven Coutre,Maximilian Diehn,Michael S. Khodadoust,Mark Roschewski,David M. Kurtz,Ash A. Alizadeh

Blood Advancesno. 3 (2023): 780-784

Cited0Views0WOSBibtex

Characterization of Low-Grade Arthralgia, Myalgia, and Musculoskeletal Pain with Ibrutinib Therapy: Pooled Analysis of Clinical Trials in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Tanya Siddiqi,Steven Coutre,Matthew McKinney,Paul M. Barr,Kerry Rogers,Ahmad Mokatrin,Rudy Valentino,Anita Szoke,Sanjay Deshpande,Angeline Zhu,Israel Arango-Hisijara,Kojo Osei-Bonsu,Michael Wang,Susan O'Brien

Leukemia & lymphoma/Leukemia and lymphoma（2022）

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn